The autophagy downstream inhibitor Baf A1 and the tandem sensor RFP-GFP-LC3B were also used to confirm that TBs-C treatment promoted the autophagic flux in lung cancer cells (Figure 4). Here, MAP1LC3B is linked to lung cancer.